Aoke Chemical terminates asset purchase plan, shares resume trading Oct 13

The deal's collapse before any binding agreement keeps it a low-liability exit, but the pledge against major restructuring for at least a month effectively caps near-term strategic optionality. For holders, the significance is less the failed acquisition than the signal that conditions were judged unripe in the short term, leaving organic operations as the only story. Whether the shares' trading resumption on October 13 reflects that reset, and whether the restructuring freeze lapses without a new plan, are the open questions.